We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Government Isn’t Being Cheated of Remdesivir Revenues: GAO
Federal Government Isn’t Being Cheated of Remdesivir Revenues: GAO
The federal government is not missing out on a piece of the action over Gilead Sciences’ antiviral Veklury (remdesivir), which the FDA approved last year to treat hospitalized COVID-19 patients, because the patents rightfully belong to the company, the Government Accountability Office (GAO) reported last week.